跳至主要内容
临床试验/NCT06323018
NCT06323018招募中不适用

Effects of Remote Ischaemic Preconditioning in Cemented Total Hip Arthroplasty: Randomized Controlled Trial

University of Tartu2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年3月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
2
主要终点
Myocardial injury

研究概览

简要总结

Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Bone cement implantation syndrome is associated with cemented hip arthroplasty and it has been shown to increase cardiovascular and renal complication and brain damage postoperatively. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.

详细描述

Total joint arthroplasty is one of the best treatment options for end-stage osteoarthritis. Cemented hip arthroplasty is mainly indicated for elderly patients with poor bone quality and multiple comorbidities. Cemented hip arthroplasty is strongly associated with bone cement implantation syndrome (BCIS). It is characterized by hypoxia, hypotension and/or unexpected loss of consciousness occurring around the time of cementation, prosthesis insertion or reduction of the joint. It has been shown to increase cardiovascular and renal complication and brain damage postoperatively. Remote-ischemic preconditioning has shown kidney, myocardial and brain injury protective effect on non-cardiac surgery patients. The aim of this project is to elucidate whether remote-ischemic preconditioning (RIPC) has multi-organ protective effect in cemented hip arthroplasty patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

盲法说明

Randomization and intervention is done by a dedicated study nurse. Patient, orthopedic surgeon, investigator and outcomes assessor and statistician are all blinded to the study intervention.

入排标准

年龄范围
65 Years 至 90 Years(Older Adult)
性别
All
接受健康志愿者

入选标准

  • age >65 years
  • undergoing total hip cemented hip arthroplasty

排除标准

  • previously diagnosed peripheral artery disease on both upper limb
  • RIPC is contraindicated

结局指标

主要结局

Myocardial injury

时间窗: From enrollment to 3. postoperative day

Peak hs-cTnT value * baseline characteristics are measured before surgery * measuring is repeated 1h after surgery and up to 3 days postoperatively

次要结局

  • Total antioxidative capacity (TAC)(From enrollment to 3. postoperative day)
  • Cardiovascular injury(From enrollment to 3. postoperative day)
  • Kidney Injury(From enrollment to 3. postoperative day)
  • Clinical serious complications(From enrollment to 1 year postoperatively)
  • Carotid-femoral pulse velocity(From enrollment to 1. postoperative day)
  • Oxidative stress level (total peroxide levels)(From enrollment to 3. postoperative day)
  • Augmentation index(From enrollment to 1. postoperative day)
  • Brain injury(From enrollment to 3. postoperative day)
  • Inflammation level(From enrollment to 3. postoperative day)
  • Low molecular weight metabolites (uM)(From enrollment to 1. postoperative day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kaspar Tootsi

Principal Investigator

University of Tartu

研究点 (2)

Loading locations...

相似试验